Two Sigma Securities, LLC Acasti Pharma Inc. Transaction History

Two Sigma Securities, LLC

  • $8.19 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.43 - $0.57 $6,487 - $8,599
15,087 New
15,087 $7,000
Q3 2022

Nov 14, 2022
SELL
$0.62 - $3.66 $5,307 - $31,329
-8,560 Reduced 33.57%
16,936 $10,000
Q2 2022

Aug 15, 2022
BUY
$0.85 - $1.29 $21,671 - $32,889
25,496 New
25,496 $22,000
Q1 2022

May 16, 2022
SELL
$0.94 - $1.43 $13,836 - $21,049
-14,720 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.07 - $2.01 $1,444 - $2,713
1,350 Added 10.1%
14,720 $19,000
Q3 2021

Nov 15, 2021
BUY
$1.96 - $4.72 $26,205 - $63,106
13,370 New
13,370 $27,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email